Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NHLBI ASTHMA CARE GUIDELINE REVISIONS ARE BEING CONSIDERED

Executive Summary

NHLBI ASTHMA CARE GUIDELINE REVISIONS ARE BEING CONSIDERED by the National Heart, Lung & Blood Institute's National Asthma Education and Prevention Program Coordinating Committee. At the committee's Nov. 21 meeting in Bethesda, Md., NHLBI Division of Lung Diseases Director Suzanne Hurd said the institute has initiated the process for revision of the guidelines by requesting the NAEPP Science Base Committee to review all the scientific literature on asthma that has been published since introduction of the guidelines in 1991 ("The Pink Sheet" Feb. 11, 1991, p. 13) and make recommendations on how the guidelines could be changed.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS025359

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel